Search alternatives:
linear decrease » linear increase (Expand Search)
nn decrease » mean decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
linear decrease » linear increase (Expand Search)
nn decrease » mean decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
-
1
Time allocation may not decrease with price for a non-linear microscopic utility of leisure.
Published 2014“…Consequently, <i>TA</i> no longer decreases but may even increase with price (A, lower panel). …”
-
2
-
3
-
4
-
5
-
6
-
7
Decreased oscillatory flow decreases <i>klf2a</i> expression.
Published 2009“…(G) <i>klf2a</i> expression decreases after 15-h lidocaine treatment (90%, <i>n</i> = 67). …”
-
8
-
9
HFD induces LDs and decreases ER and mitochondria in nephrocytes.
Published 2021“…<b><a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001230#pbio.3001230.s007" target="_blank">S2 Data</a></b> provides the source data used for all graphs and statistical analyses. …”
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Factors associated with decreased FVC by multiple linear regression analysis.
Published 2015“…<p>R<sup>2</sup> =. 39</p><p>Factors associated with decreased FVC by multiple linear regression analysis.…”
-
19
Bioluminescence decreased following <i>ex vivo</i> collagenase digestion of transgenic femora.
Published 2015“…(A) The femur showed a linear decrease (r = -0.619, p = 0.0452) after 6 hours in digestion. …”
-
20
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”